Search Results - "Feldman, Paul L."

Refine Results
  1. 1

    Gut hormone pharmacology of a novel GPR119 agonist (GSK1292263), metformin, and sitagliptin in type 2 diabetes mellitus: results from two randomized studies by Nunez, Derek J, Bush, Mark A, Collins, David A, McMullen, Susan L, Gillmor, Dawn, Apseloff, Glen, Atiee, George, Corsino, Leonor, Morrow, Linda, Feldman, Paul L

    Published in PloS one (03-04-2014)
    “…GPR119 receptor agonists improve glucose metabolism and alter gut hormone profiles in animal models and healthy subjects. We therefore investigated the…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Insights into the Chemical Discovery of Remifentanil by Feldman, Paul L.

    Published in Anesthesiology (Philadelphia) (01-05-2020)
    “…Design, Synthesis, and Pharmacological Evaluation of Ultrashort- to Long-acting Opioid Analgetics. By Feldman PL, James MK, Brackeen MF, Bilotta JM, Schuster…”
    Get full text
    Journal Article
  4. 4

    A 28-Day Toxicity Study of Tenofovir Alafenamide Hemifumarate by Subcutaneous Infusion in Rats and Dogs by Zane, Doris, Roller, Shane, Shelton, Josephine, Singh, Roshni, Jain, Rachna, Wang, Yan, Yang, Bing, Felx, Melanie, Alessi, Thomas, Feldman, Paul L

    Published in Microbiology spectrum (03-09-2021)
    “…The toxicity of tenofovir alafenamide (TAF) hemifumarate (HF) was evaluated when administered by continuous subcutaneous (s.c.) infusion via an external…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Development and Regulatory Challenges for Peptide Therapeutics by Zane, Doris, Feldman, Paul L., Sawyer, Tomi, Sobol, Zhanna, Hawes, Jessica

    Published in International journal of toxicology (01-03-2021)
    “…There has been an increased interest in and activity for the use of peptide therapeutics to treat a variety of human diseases. The number of peptide drugs…”
    Get full text
    Journal Article
  7. 7

    Quality guidelines for oral drug candidates: dose, solubility and lipophilicity by Bayliss, Martin K., Butler, James, Feldman, Paul L., Green, Darren V.S., Leeson, Paul D., Palovich, Michael R., Taylor, Anthony J.

    Published in Drug discovery today (01-10-2016)
    “…[Display omitted] •Experimental properties of GSK's oral portfolio were compared with marketed drugs.•Properties were dose, solubility and the property…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10

    CNS 7056: a novel ultra-short-acting Benzodiazepine by Kilpatrick, Gavin J, McIntyre, Margaret S, Cox, Richard F, Stafford, Jeffrey A, Pacofsky, Gregory J, Lovell, Gwyer G, Wiard, Robert P, Feldman, Paul L, Collins, Holly, Waszczak, Barbara L, Tilbrook, Gary S

    Published in Anesthesiology (Philadelphia) (01-07-2007)
    “…A new benzodiazepine derivative, CNS 7056, has been developed to permit a superior sedative profile to current agents, i.e., more predictable fast onset, short…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19

    CNS 7056 by Kilpatrick, Gavin J., McIntyre, Margaret S., Cox, Richard F., Stafford, Jeffrey A., Pacofsky, Gregory J., Lovell, Gwyer G., Wiard, Robert P., Feldman, Paul L., Collins, Holly, Waszczak, Barbara L., Tilbrook, Gary S.

    Published in Anesthesiology (Philadelphia) (01-07-2007)
    “…Abstract Background: A new benzodiazepine derivative, CNS 7056, has been developed to permit a superior sedative profile to current agents, i.e., more…”
    Get full text
    Journal Article
  20. 20